Search Results 751-760 of 18186 for monoclonal antibody
Monoclonal antibodies help COVID-19 patients avoid hospitalization featured image. COVID-19. Monoclonal antibodies help COVID-19 patients avoid hospitalization.
Three monoclonal antibody therapies — eculizumab, inebilizumab and satralizumab — have been approved for adults with NMOSD and AQP4-IgG autoantibodies.
Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...
Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
For various rare immunobullous diseases, detection of a circulating autoantibody is necessary for accurate diagnosis. ... Monoclonal antibodies, such as rituximab ...
Monoclonal antibodies, such as nivolumab, may interfere with the ability of tumor cells to grow and spread. Giving nivolumab before nephrectomy may make the ...
Hesitant about COVID-19 vaccine development? · Research · Monoclonal antibodies help COVID-19 patients avoid hospitalization featured image · Strong immune ...
... monoclonal antibody that binds to toxin-B for the prevention of recurrences. Because neither standard-of-care antibiotics nor bezlotoxumab repairs the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.